Phân tích in silico các đột biến liên quan đến nhiễm virus viêm gan B ẩn (HBV) tại Nam Phi

Adzhubei IA, Schmidt S, Peshkin L, Ramensky VE, Gerasimova A, Bork P, Kondrashov AS, Sunyaev SR (2010) A method and server for predicting damaging missense mutations. Nat Methods 7:248–249 Anderson M, Choga WT, Moyo S, Bell TG, Mbangiwa T, Phinius BB, Bhebhe L, Sebunya TK, Makhema J, Marlink R, Kramvis A, Essex M, Musonda RM, Blackard JT, Gaseitsiwe S (2018) In silico analysis of hepatitis B virus occult associated mutations in Botswana using a novel algorithm. Genes 9:E420 Araujo NM, Branco-Vieira M, Silva AC, Pilotto JH, Grinsztejn B, de Almeida AJ, Trepo C, Gomes S (2008) Occult hepatitis B virus infection in HIV-infected patients: evaluation of biochemical, virological and molecular parameters. Hepatol Res 38:1194–1203 Bauer T, Weinberger K, Jilg W (2002) Variants of two major T cell epitopes within the hepatitis B surface antigen are not recognized by specific T helper cells of vaccinated individuals. Hepatology 35:455–465 Bell TG, Kramvis A (2015) Bioinformatics tools for small genomes, such as hepatiti B virus. Viruses 7:781–797 Bell TG, Yousif M, Kramvis A (2016) Bioinformatic curation and alignment of genotyped hepatitis B virus (HBV) sequence data from the GenBank public database. Springerplus 5:1896 Bica I, McGovern B, Dhar R, Stone D, McGowan K, Scheib R, Snydman D (2001) Increasing mortality due to end-stage liver disease in patients with human immunodeficiency virus infection. Clin Infect Dis 32:492–497 Biswas S, Candotti D, Allain JP (2013) Specific amino acid substitutions in the S protein prevent its excretion in vitro and may contribute to occult hepatitis B virus infection. J Virol 87:7882–7892 Bodsworth N, Donovan B, Nightingale B (1989) The effect of concurrent human immunodeficiency virus infection on chronic hepatitis B: a study of 150 homosexual men. J Infect Dis 160:577–582 Burnett RJ, Ngobeni JM, François G, Hoosen AA, Leroux-Roels G, Meheus A, Mphahlele M (2007) Increased exposure to hepatitis B virus infection in HIV-positive South African antenatal women. Int J STD AIDS 18:152–156 Candotti D, Grabarczyk P, Ghiazza P, Roig R, Casamitjana N, Iudicone P, Schmidt M, Bird A, Crookes R, Brojer E, Miceli M, Amiri A, Li C, Allain J (2008) Characterization of occult hepatitis B virus from blood donors carrying genotype A2 or genotype D strains. J Hepatol 49:537–547 Chamorro AJ, Casado JL, Bellido D, Moreno S (2005) Reactivation of hepatitis B in an HIV-infected patient with antibodies against hepatitis B core antigen as the only serological marker. Eur J Clin Microbiol Infect Dis 24:492–494 Chaudhuri V, Tayal R, Nayak B, Acharya SK, Panda S (2004) Occult hepatitis B virus infection in chronic liver disease: full-length genome and analysis of mutant surface promoter. Gastroenterology 127:1356–1371 Chen CH, Changchien CS, Lee CM, Tung WC, Hung CH, Hu TH, Wang JH, Wang JC, Lu S (2009) A study on sequence variations in pre-S/surface, X and enhancer II/core promoter/precore regions of occult hepatitis B virus in non-B, non-C hepatocellular carcinoma patients in Taiwan. Int J Cancer 125:621–629 Choi Y, Sims GE, Murphy S, Miller JR, AP C (2012) Predicting the functional effect of amino acid substitutions and indels. PLoS One, p e46688 Chua PK, Wang RY, Lin MH, Masuda T, Suk FM, Shih C (2005) Reduced secretion of virions and hepatitis B virus (HBV) surface antigen of a naturally occurring HBV variant correlates with the accumulation of the small S envelope protein in the endoplasmic reticulum and Golgi apparatus. J Virol 79:13483–13496 Colin JF, Cazals-Hatem D, Loriot MA, Martinot-Peignoux M, Pham BN, Auperin A, Degott C, Benhamou JP, Erlinger S, Valla D, Marcellin P (1999) Influence of human immunodeficiency virus infection on chronic hepatitis B in homosexual men. Hepatology 29:1306–1310 Descos B, Scotto J, Fayol V, Huet JY, Pichoud C, Hermier M, Ville G, Charvet F, Dargent D, Thoulon JM et al (1987) Anti-HBc screening for the prevention of perinatal transmission of hepatitis B virus in France. Infection 15:434–439 El Chaar M, Candotti D, Crowther RA, Allain J (2010) Impact of hepatitis B virus surface protein mutations on the diagnosis of occult hepatitis B virus infection. Hepatology 52:1600–1610 Elkady A, Iijima S, Aboulfotuh S, Mostafa Ali E, Sayed D, Abdel-Aziz NM, Ali AM, Murakami S, Isogawa M, Tanaka Y (2017) Characteristics of escape mutations from occult hepatitis B virus infected patients with hematological malignancies in South Egypt. World J Hepatol 9:477–486 Filippini P, Coppola N, Pisapia R, Scolastico C, Marrocco C, Zaccariello A, Nacca C, Sagnelli C, De Stefano G, Ferraro T, De Stefano C, Sagnelli E (2006) Impact of occult hepatitis B virus infection in HIV patients naive for antiretroviral therapy. AIDS 20:1253–1260 Firnhaber C, Viana R, Reyneke A, Schultze D, Malope B, Maskew M, Di Bisceglie A, MacPhail P, Sanne I, Kew M (2009) Occult hepatitis B virus infection in patients with isolated core antibody and HIV co-infection in an urban clinic in Johannesburg, South Africa. Int J Infect Dis 13:488–492 Fujise K, Tatsuzawa K, Kono M, Hoshina S, Tsubota A, Niiya M, Namiki Y, Tada N, Tajiri H (2011) A mutation of the start codon in the X region of hepatitis B virus DNA in a patient with non-B, non-C chronic hepatitis. World J Hepatol 3:56–60 Gilson RJ, Hawkins AE, Beecham MR, Ross E, Waite J, Briggs M, McNally T, Kelly GE, Tedder RS, Weller I (1997) Interactions between HIV and hepatitis B virus in homosexual men: effects on the natural history of infection. AIDS 11:597–606 Hass M, Hannoun C, Kalinina T, Sommer G, Manegold C, Günther S (2005) Functional analysis of hepatitis B virus reactivating in hepatitis B surface antigen-negative individuals. Hepatology 42:93–103 Hecht M, Bromberg Y, Rost B (2015) Better prediction of functional effects for sequence variants. BMC Genomics 16:S1 Hofer M, Joller-Jemelka HI, Grob PJ, Lüthy R, Opravil M (1998) Frequent chronic hepatitis B virus infection in HIV-infected patients positive for antibody to hepatitis B core antigen only. Swiss HIV Cohort Study. Eur J Clin Microbiol Infect Dis 17:6–13 Hoofnagle JH, Seefe LB, Bales ZB, Zimmerman H (1978) Type B hepatitis after transfusion with blood containing antibody to hepatitis B core antigen. N Engl J Med 298:1379–1383 Hu K (2002) Occult hepatitis B virus infection and its clinical implications. J Viral Hepatitis 9:243–257 Huang CH, Yuan Q, Chen PJ, Zhang YL, Chen CR, Zheng QB, Yeh SH, Yu H, Xue Y, Chen YX, Liu PG, Ge SX, Zhang J, Xia N (2012) Influence of mutations in hepatitis B virus surface protein on viral antigenicity and phenotype in occult HBV strains from blood donors. J Hepatol 57:720–729 Ijaz S, Szypulska R, Andrews N, Tedder R (2012) Investigating the impact of hepatitis B virus surface gene polymorphism on antigenicity using ex vivo phenotyping. J Gen Virol 93:2473–2479 Ikeda K, Kobayashi M, Someya T, Saitoh S, Hosaka T, Akuta N, Suzuki F, Suzuki Y, Arase Y, Kumada H (2009) Occult hepatitis B virus infection increases hepatocellular carcinogenesis by eight times in patients with non-B, non-C liver cirrhosis: a cohort study. J Viral Hepatitis 16:437–443 Ito K, Qin Y, Guarnieri M, Garcia T, Kwei K, Mizokami M, Zhang J, Li J, Wands JR, Tong S (2010) Impairment of hepatitis B virus virion secretion by single-amino-acid substitutions in the small envelope protein and rescue by a novel glycosylation site. J Virol 84:12850–12861 Jeantet D, Chemin I, Mandrand B, Zoulim F, Trepo C, Kay A (2002) Characterization of two hepatitis B virus populations isolated from a hepatitis B surface antigen-negative patient. Hepatology 35:1215–1224 Kalinina T, Iwanski A, Will H, Sterneck M (2003) Deficiency in virion secretion and decreased stability of the hepatitis B virus immune escape mutant G145R. Hepatology 38:1274–1281 Kao JH, Chen PJ, Lai MY, Chen D (2002) Sequence analysis of pre-S/surface and pre-core/core promoter genes of hepatitis B virus in chronic hepatitis C patients with occult HBV infection. J Med Virol 68:216–220 Khan N, Guarnieri M, Ahn SH, Li J, Zhou Y, Bang G, Kim KH, Wands JR, Tong S (2004) Modulation of hepatitis B virus secretion by naturally occurring mutations in the S gene. J Virol 78:3262–3270 Koyama H, Nishizawa Y, Kinoshita H, Fujimoto T, Morii H (1988) Hepatocellular carcinoma with occult chronic hepatitis–hepatitis B virus as a pathogenetic factor of hepatocellular carcinoma. Osaka City Med J 34:51–66 Kramvis A, Kew M (2007) Epidemiology of hepatitis B virus in Africa, its genotypes and clinical associations of genotypes. Hepatol Res 37:S9–S19 Kumar GT, Kazim SN, Kumar M, Hissar S, Chauhan R, Basir SF, Sarin S (2009) Hepatitis B virus genotypes and hepatitis B surface antigen mutations in family contacts of hepatitis B virus infected patients with occult hepatitis B virus infection. J Gastroenterol Hepatol 24:588–598 Kwei K, Tang X, Lok AS, Sureau C, Garcia T, Li J, Wands J, S T, (2013) Impaired virion secretion by hepatitis B virus immune escape mutants and its rescue by wild-type envelope proteins or a second-site mutation. J Virol 87:2352–2357 Lacombe K, Boyd A, Lavocat F, Pichoud C, Gozlan J, Miailhes P, Lascoux-Combe C, Vernet G, Girard PM, Zoulim F (2013) High incidence of treatment-induced and vaccine-escape hepatitis B virus mutants among human immunodeficiency virus/hepatitis B-infected patients. Hepatology 58:912–922 Liu CJ, Lo SC, Kao JH, Tseng PT, Lai MY, Ni YH, Yeh SH, Chen PJ, Chen D (2006) Transmission of occult hepatitis B virus by transfusion to adult and pediatric recipients in Taiwan. J Hepatol 44:39–46 Locarnini SA, Yuen L (2010) Molecular genesis of drug-resistant and vaccine-escape HBV mutants. Antivir Ther 15:451–461 Lukhwareni A, Burnett RJ, Selabe SG, Mzileni MO, Mphahlele M (2009) Increased detection of HBV DNA in HBsAg-positive and HBsAg-negative South African HIV/AIDS patients enrolling for highly active antiretroviral therapy at a Tertiary Hospital. J Med Virol 81:406–412 Margeridon S, Lachaux A, Trepo C, Zoulim F, Kay A (2005) A quasi-monoclonal anti-HBs response can lead to immune escape of “wild-type” hepatitis B virus. J Gen Virol 86:1687–1693 Martin CM, Welge JA, Rouster SD, Shata MT, Sherman KE, Blackard J (2012) Mutations associated with occult hepatitis B virus infection result in decreased surface antigen expression in vitro. J Viral Hepatitis 19:716–723 Matsuoka S, Nirei K, Tamura A, Nakamura H, Matsumura H, Oshiro S, Arakawa Y, Yamagami H, Tanaka N, Moriyama M (2008) Influence of occult hepatitis B virus coinfection on the incidence of fibrosis and hepatocellular carcinoma in chronic hepatitis C. Intervirology 51:352–361 McGovern B (2007) The epidemiology, natural history and prevention of hepatitis B: implications of HIV coinfection. Antivir Ther 12:H3–H13 Mello FC, Martel N, Gomes SA, Araujo NM (2011) Expression of Hepatitis B Virus Surface Antigen Containing Y100C Variant Frequently Detected in Occult HBV Infection. Hepat Res Treat 2011:695859 Moerman B, Moons V, Sommer H, Schmitt Y, Stetter M (2004) Evaluation of sensitivity for wild type and mutant forms of hepatitis B surface antigen by four commercial HBsAg assays. Clin Lab 50:159–162 Mphahlele MJ, Lukhwareni A, Burnett RJ, Moropeng LM, Ngobeni J (2006) High risk of occult hepatitis B virus infection in HIV-positive patients from South Africa. J Clin Virol 35:14–20 Mrani S, Chemin I, Menouar K, Guillaud O, Pradat P, Borghi G, Trabaud MA, Chevallier P, Chevallier M, Zoulim F, Trépo C (2007) Occult HBV infection may represent a major risk factor of non-response to antiviral therapy of chronic hepatitis C. J Med Virol 79:1075–1081 Ou L, Przybilla MJ, Whitley CB (2017) Phenotype prediction for mucopolysaccharidosis type I by in silico analysis. Orphanet J Rare Dis 12:125 Patel P, Davis S, Tolle M, Mabikwa V, Anabwani G (2011) Prevalence of hepatitis B and hepatitis C coinfections in an adult HIV centre population in Gaborone, Botswana. Am J Trop Med Hyg 85:390–394 Pollicino T, Squadrito G, Cerenzia G, Cacciola I, Raffa G, Craxi A, Farinati F, Missale G, Smedile A, Tiribelli C, Villa E, Raimondo G (2004) Hepatitis B virus maintains its pro-oncogenic properties in the case of occult HBV infection. Gastroenterology 126:102–110 Powell EA, Gededzha MP, Rentz M, Rakgole NJ, Selabe SG, Seleise TA, Mphahlele MJ, Blackard J (2015) Mutations associated with occult hepatitis B in HIV-positive South Africans. J Med Virol 2015:388–400 Powell EA, Boyce CL, Gededzha MP, Selabe SG, Mphahlele MJ, Blackard J (2016) Functional analysis of “a” determinant mutations associated with occult HBV in HIV-positive South Africans. J Gen Virol 97:1615–1624 Sadowski CE, Kohlstedt D, Meisel C, Keller K, Becker K, Mackenroth L, Rump A, Schröck E, Wimberger P, Kast K (2017) BRCA1/2 missense mutations and the value of in-silico analyses. Eur J Med Genet 60:572–577 Salmon-Ceron D, Lewden C, Morlat P, Bévilacqua S, Jougla E, Bonnet F, Héripret L, Costagliola D, May T, G; C, group TMs (2005) Liver disease as a major cause of death among HIV infected patients: role of hepatitis C and B viruses and alcohol. J Hepatol 42:799–805 Schories M, Peters T, Rasenack J (2000) Isolation, characterization and biological significance of hepatitis B virus mutants from serum of a patient with immunologically negative HBV infection. J Hepatol 33:799–811 Schultz AK, Bulla I, Abdou-Chekaraou M, Gordien E, Morgenstern B, Zoaulim F, Dény P, Stanke M (2012) jpHMM: recombination analysis in viruses with circular genomes such as the hepatitis B virus. Nucleic Acids Res 40:W193–W198 Scully LJ, Sung H, Pennie R, Gill P (1994) Detection of hepatitis B virus DNA in the serum of Canadian hepatitis B surface antigen negative, anti-HBc positive individuals, using the polymerase chain reaction. J Med Virol 44:293–297 Seddigh-Tonekaboni S, Waters JA, Jeffers S, Gehrke R, Ofenloch B, Horsch A, Hess G, Thomas HC, Karayiannis P (2000) Effect of variation in the common “a” determinant on the antigenicity of hepatitis B surface antigen. J Med Virol 60:113–121 Shiota G, Oyama K, Udagawa A, Tanaka K, Nomi T, Kitamura A, Tsutsumi A, Noguchi N, Takano Y, Yashima K, Kishimoto Y, Suou T, Kawasaki H (2000) Occult hepatitis B virus infection in HBs antigen-negative hepatocellular carcinoma in a Japanese population: involvement of HBx and p53. J Med Virol 62:151–158 Svicher V, Cento V, Bernassola M, Neumann-Fraune M, Van Hemert F, Chen M, Salpini R, Liu C, Longo R, Visca M, Romano S, Micheli V, Bertoli A, Gori C, Ceccherini-Silberstein F, Sarrecchia C, Andreoni M, Angelico M, Ursitti A, Spanò A, Zhang JM, Verheyen J, Cappiello G, Perno C (2012) Novel HBsAg markers tightly correlate with occult HBV infection and strongly affect HBsAg detection. Antiviral Res 93:86–93 Sánchez-Quijano A, Jauregui JI, Leal M, Pineda JA, Castilla A, Abad MA, Civeira MP, García de Pesquera F, Prieto J, Lissen E (1993) Hepatitis B virus occult infection in subjects with persistent isolated anti-HBc reactivity. J Hepatol 17:288–293 Tedaldi EM, Baker RK, Moorman AC, Alzola CF, Furhrer J, McCabe RE, Wood KC, Holmberg SD, HIV, Outpatient, Study, (HOPS), Investigators (2003) Influence of coinfection with hepatitis C virus on morbidity and mortality due to human immunodeficiency virus infection in the era of highly active antiretroviral therapy. Clin Infect Dis 36:363–367 Thiers V, Nakajima E, Kremsdorf D, Mack D, Schellekens H, Driss F, Goudeau A, Wands J, Sninsky J, Tiollais P et al (1988) Transmission of hepatitis B from hepatitis-B-seronegative subjects. Lancet 2:1273–1276 Thio CL, Seaberg EC, Skolasky R Jr, Phair J, Visscher B, Munoz A, Thomas DL (2002) HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study (MACS). Lancet 360:1921–1926 Thompson J, Gibson T, Plewniak F, Jeanmougin F, Higgins D (1997) The CLUSTAL X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acids Res 25:4876–4882 Velay A, Jeulin H, Eschlimann M, Malvé B, Goehringer F, Bensenane M, Frippiat JP, Abraham P, Ismail AM, Murray JM, Combet C, Zoulim F, Bronowicki JP, Schvoerer E (2016) Characterization of hepatitis B virus surface antigen variability and impact on HBs antigen clearance under nucleos(t)ide analogue therapy. J Viral Hepat 23:387–398 Vivekanandan P, Kannangai R, Ray SC, Thomas DL, Torbenson M (2008) Comprehensive genetic and epigenetic analysis of occult hepatitis B from liver tissue samples. Clin Infect Dis 46:1227–1236 Wang HC, Huang W, Lai MD, Su I (2006) Hepatitis B virus pre-S mutants, endoplasmic reticulum stress and hepatocarcinogenesis. Cancer Sci 97:683–688 Warner N, Locarnini S (2008) The antiviral drug selected hepatitis B virus rtA181T/sW172* mutant has a dominant negative secretion defect and alters the typical profile of viral rebound. Hepatology 48:88–98 Weinberger KM, Bauer T, Böhm S, Jilg W (2000) High genetic variability of the group-specific a-determinant of hepatitis B virus surface antigen (HBsAg) and the corresponding fragment of the viral polymerase in chronic virus carriers lacking detectable HBsAg in serum. J Gen Virol 81:1165–1174 Wester CW, Bussmann H, Moyo S, Avalos A, Gaolathe T, Ndwapi N, Essex M, MacGregor RR, Marlink R (2006) Serological evidence of HIV-associated infection among HIV-1-infected adults in Botswana. Clin Infect Dis 43:1612–1615 World Health Organization (2013) Hepatitis B fact sheet. World Health Organization (2020) Hepatitis B fact sheet. Wu C, Deng W, Deng L, Cao L, Qin B, Li S, Wang Y, Pei R, Yang D, Lu M, X C, (2012) Amino acid substitutions at positions 122 and 145 of hepatitis B virus surface antigen (HBsAg) determine the antigenicity and immunogenicity of HBsAg and influence in vivo HBsAg clearance. J Virol 86:4658–4669 Xiang KH, Michailidis E, Ding H, Peng YQ, Su MZ, Li Y, Liu XE, Dao Thi VL, Wu XF, Schneider WM, Rice CM, Zhuang H, Li T (2017) Effects of amino acid substitutions in hepatitis B virus surface protein on virion secretion, antigenicity, HBsAg and viral DNA. J Hepatol 66:288–296 Xu Z, Jensen G, Yen T (1997) Activation of hepatitis B virus S promoter by the viral large surface protein via induction of stress in the endoplasmic reticulum. J Virol 71:7387–7392 Zheng X, Weinberger KM, Gehrke R, Isogawa M, Hilken G, Kemper T, Xu Y, Yang D, Jilg W, Roggendorf M, Lu M (2004) Mutant hepatitis B virus surface antigens (HBsAg) are immunogenic but may have a changed specificity. Virology 329:454–464 Zhou H, Gewaily D, Ahn SH, Preskill C, Wang Y, Zong L, Zhang J, Han KH, Wands J, Li J, Tong S (2017) Sequence analysis and functional characterization of full-length hepatitis B virus genomes from Korean cirrhotic patients with or without liver cancer. Virus Res 235:86–95